Non-Small Cell Lung Cancer Market Size, Share, Growth Analysis, By Therapy(Targeted Therapy, Immunotherapy, Chemotherapy), By Region - Industry Forecast 2025-2032

Non-Small Cell Lung Cancer Market size was valued at USD 26.94 Billion in 2023 and is poised to grow from USD 30.68 Billion in 2024 to USD 86.94 Billion by 2032, growing at a CAGR of 13.9% during the forecast period (2025-2032).

The introduction of immune checkpoint inhibitors (ICIs) into the first-line context is one of the main drivers influencing market revenue growth. Eighty to eighty-five percent of lung cancer occurrences worldwide are non-small cell lung cancer, and because of this high percentage, the majority of market leaders are concentrating on constantly developing new therapies and enhancing the effectiveness of already-available medications. The market expansion is also attributable to lung cancer's notoriety as one of the most prevalent malignancies that causes a sizable number of fatalities worldwide. Increased non-small cell lung cancer diagnoses and greater public knowledge of the condition in developed and developing nations both contribute to the growth of the non-small cell lung cancer market. The inclusion of non-small cell cancer medicines in the pipelines of key market participants, together with increased investment in research and development activities by top businesses, is boosting the global market's growth.